CLINICAL_TRIALS
trial_result
· 2022-02-17
Clinical Trial Update: Multitarget Therapy for Idiopathic Membranous Nephropathy [Phase 4]
Summary
Phase 4 clinical trial investigating a multitarget therapy for idiopathic membranous nephropathy has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Beijing Friendship Hospital | Conditions: Efficacy | Phase 4 | Status: COMPLETED